Company profile for Nordic Nanovector

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodg...
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Norway
Address
Address
Kjelsåsveien 168 B 0884 Oslo
Telephone
Telephone
+47 22 18 33 01
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/nordic-nanovector-announces-agreement-to-acquire-thor-medical-an-emerging-producer-of-alpha-emitters-for-radiopharmaceuticals-to-treat-cancer-301844111.html

PR NEWSWIRE
06 Jun 2023

https://www.prnewswire.com/news-releases/nordic-nanovector--annual-general-meeting-postponed-301786771.html

PR NEWSWIRE
31 Mar 2023

https://www.prnewswire.com/news-releases/nordic-nanovector-asa-invitation-to-second-half-and-full-year-2022-results-presentation-and-webcast-301751575.html

PR NEWSWIRE
21 Feb 2023

https://www.prnewswire.com/news-releases/nordic-nanovector-asa---notice-of-extraordinary-general-meeting-on-3-january-2023-301701373.html

PRNEWSWIRE
13 Dec 2022
Nordic Nanovector faces board walkout after failed APIM merger
Nordic Nanovector faces board walkout after failed APIM merger

13 Dec 2022

// James Waldron FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/nordic-nanovector-scrambles-recruit-new-directors-ceo-after-mass-boardroom-walkout-wake

James Waldron FIERCEBIOTECH
13 Dec 2022

https://www.prnewswire.com/news-releases/nordic-nanovector-update-following-shareholder-vote-against-proposed-merger-with-apim-therapeutics-301699485.html

PRNEWSWIRE
09 Dec 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty